Ideas to action: independent research for global prosperity
Search
Filters:
Experts
Facet Toggle
Topics
Facet Toggle
Content Type
Facet Toggle
Publication Type
Facet Toggle
Time Frame
Facet Toggle
Blog Post
July 20, 2022
Get ready for Pandemic Proof, a new podcast from the Center for Global Development. Hosted by CGD's Amanda Glassman and Javier Guzman and featuring guests from around the world, Pandemic Proof will confront weaknesses in the global architecture for pandemic preparedness and response, and explore pol...
Blog Post
June 28, 2022
CGD has set up a working group to examine different ways to purchase antimicrobials in LMICs in order to identify actionable policies to improve access and stewardship for key products and increase funding for research into new ones. We are launching today the Working Group’s first working paper.
Blog Post
January 12, 2022
In November, we co-hosted an online event with USAID MTaPS and heard from experts in LMIC national regulatory authorities, donor agencies, and academia on supporting regulators and streamlining registration processes to improve the availability of quality assured medicines around the world. In this ...
POLICY PAPERS
October 28, 2021
Results-based financing (RBF) is one of several broad approaches to finance official development assistance (ODA) “that attempt[s] to connect at least a portion of payment to the verified achievement of results.” Despite some relatively high-profile programs and pilots—and broad interest and curiosi...
Blog Post
August 02, 2021
Access to safe, effective, and affordable essential medicines is an integral global health goal, and all the more important during a public health emergency like COVID-19. Supply chain inefficiencies, procurement capacity constraints, and financial difficulties impede access to affordable, quality m...
Blog Post
June 04, 2021
Since March of 2020, COVID-19 changed most aspects of life as we knew it, from our personal day-to-day activities to the systems, processes, and structures that keep the global economy interconnected and moving. This included pharmaceutical production and distribution, where anecdotal evidence ...